These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31518663)

  • 1. Cisplatin induces chemoresistance through the PTGS2-mediated anti-apoptosis in gastric cancer.
    Lin XM; Li S; Zhou C; Li RZ; Wang H; Luo W; Huang YS; Chen LK; Cai JL; Wang TX; Zhang QH; Cao H; Wu XP
    Int J Biochem Cell Biol; 2019 Nov; 116():105610. PubMed ID: 31518663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib enhanced the cytotoxic effect of cisplatin in drug-resistant human gastric cancer cells by inhibition of cyclooxygenase-2.
    Xu HB; Shen FM; Lv QZ
    Eur J Pharmacol; 2015 Dec; 769():1-7. PubMed ID: 26407653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
    Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
    Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.
    Washington MN; Suh G; Orozco AF; Sutton MN; Yang H; Wang Y; Mao W; Millward S; Ornelas A; Atkinson N; Liao W; Bast RC; Lu Z
    Cell Death Dis; 2015 Aug; 6(8):e1836. PubMed ID: 26247722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib enhanced the cytotoxic effect of cisplatin in chemo-resistant gastric cancer xenograft mouse models through a cyclooxygenase-2-dependent manner.
    Xu HB; Shen FM; Lv QZ
    Eur J Pharmacol; 2016 Apr; 776():1-8. PubMed ID: 26879869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
    Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
    Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Prostaglandin-Endoperoxide Synthase-2 in Chemoresistance of Non-Small Cell Lung Cancer.
    Lin XM; Luo W; Wang H; Li RZ; Huang YS; Chen LK; Wu XP
    Front Pharmacol; 2019; 10():836. PubMed ID: 31440159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginkgo biloba extract enhances chemotherapy sensitivity and reverses chemoresistance through suppression of the KSR1-mediated ERK1/2 pathway in gastric cancer cells.
    Liu SQ; Xu CY; Qin MB; Tan L; Zhuge CF; Mao YB; Lai MY; Huang JA
    Oncol Rep; 2015 Jun; 33(6):2871-82. PubMed ID: 25962735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troxerutin (TXN) potentiated 5-Fluorouracil (5-Fu) treatment of human gastric cancer through suppressing STAT3/NF-κB and Bcl-2 signaling pathways.
    Xu GY; Tang XJ
    Biomed Pharmacother; 2017 Aug; 92():95-107. PubMed ID: 28531805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism study of lentiviral vector carrying methioninase enhances the sensitivity of drug-resistant gastric cancer cells to Cisplatin.
    Xin L; Yang WF; Zhang HT; Li YF; Liu C
    Br J Cancer; 2018 May; 118(9):1189-1199. PubMed ID: 29576621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcuminoid WZ35 synergize with cisplatin by inducing ROS production and inhibiting TrxR1 activity in gastric cancer cells.
    He W; Xia Y; Cao P; Hong L; Zhang T; Shen X; Zheng P; Shen H; Liang G; Zou P
    J Exp Clin Cancer Res; 2019 May; 38(1):207. PubMed ID: 31113439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression.
    Cho HJ; Baek KE; Park SM; Kim IK; Nam IK; Choi YL; Park SH; Im MJ; Choi J; Ryu J; Kim JW; Lee CW; Kang SS; Yoo J
    Cancer Lett; 2011 Dec; 311(1):48-56. PubMed ID: 21752536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction.
    Wu H; Liu S; Gong J; Liu J; Zhang Q; Leng X; Zhang N; Li Y
    Cancer Lett; 2017 May; 393():22-32. PubMed ID: 28216375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
    Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TXNL1 induces apoptosis in cisplatin resistant human gastric cancer cell lines.
    Ni P; Xu W; Zhang Y; Chen Q; Li A; Wang S; Xu S; Zhou J
    Curr Cancer Drug Targets; 2015; 14(9):850-9. PubMed ID: 25348020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
    Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
    Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lycopene Inhibits Activation of Epidermal Growth Factor Receptor and Expression of Cyclooxygenase-2 in Gastric Cancer Cells.
    Han H; Lim JW; Kim H
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31491956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircRNACCDC66 regulates cisplatin resistance in gastric cancer via the miR-618/BCL2 axis.
    Zhang Q; Miao Y; Fu Q; Hu H; Chen H; Zeng A; Jin Y; Jiang Y; Qian L; Wu L; Xu L; Wang G; Qiu L; Huang X; Xia Y
    Biochem Biophys Res Commun; 2020 Jun; 526(3):713-720. PubMed ID: 32253030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HZ08 reverse the aneuploidy-induced cisplatin-resistance in Gastric cancer by modulating the p53 pathway.
    Tang X; Hu G; Xu C; Ouyang K; Fang W; Huang W; Zhang J; Li F; Wang K; Qin X; Li Y
    Eur J Pharmacol; 2013 Nov; 720(1-3):84-97. PubMed ID: 24183976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.